Literature DB >> 14499704

The apolipoprotein E epsilon 4 allele is not a risk factor for Turkish breast cancer patients.

Ilhan Yaylim, Nilüfer Bozkurt, Hülya Yilmaz, Turgay Isbir, Nilgün Isik, Soykan Arikan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14499704     DOI： 10.1016/s0165-4608(03)00124-9

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN： 0165-4608


× No keyword cloud information.
  4 in total

1.  Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study.

Authors:  Brenna C McDonald; Susan K Conroy; Dori J Smith; John D West; Andrew J Saykin
Journal:  Brain Behav Immun       Date:  2012-05-18       Impact factor: 7.217

2.  Apolipoprotein E Allelic Frequency Altered in Women with Early-onset Breast Cancer.

Authors:  Tirtsa Porrata-Doria; Jaime L Matta; Summer F Acevedo
Journal:  Breast Cancer (Auckl)       Date:  2010-05-24

3.  Apolipoprotein E (APOE) Polymorphisms and Susceptibility to Breast Cancer: A Meta-Analysis.

Authors:  Mostafa Saadat
Journal:  Cancer Res Treat       Date:  2012-06-30       Impact factor: 4.679

4.  The relationship between apolipoprotein E gene ε2/ε3/ε4 polymorphism and breast cancer risk: a systematic review and meta-analysis.

Authors:  Yun-Long Liu; Hao-Min Zhang; Hong-Ming Pan; Yu-Hang Bao; Jing Xue; Tian-Chang Wang; Xiao-Cheng Dong; Xiao-Ling Li; Hong-Guang Bao
Journal:  Onco Targets Ther       Date:  2016-03-07       Impact factor: 4.147
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.